HIV-2 as a model to identify a functional HIV cure

Area of Science:

• Virology
• Immunology
• Infectious Diseases

Background:

• Two major human immunodeficiency virus (HIV) types exist: HIV-1, which is pandemic and aggressive, and HIV-2, primarily found in West Africa with lower pathogenicity.
• Despite decades of research since the discovery of Acquired Immunodeficiency Syndrome (AIDS), a definitive cure or vaccine for HIV remains elusive.
• Functional cures and vaccines, aiming for sustained viral control without lifelong treatment, are considered more attainable goals for managing the HIV pandemic.

Purpose of the Study:

• To explore the potential of using HIV-2 as a model system to identify mechanisms for a functional HIV cure.
• To understand the differences between HIV-1 and HIV-2 infections and their cross-reactive effects in dual infections.
• To uncover virus-host interactions that could be targeted for novel therapeutic strategies against HIV.

Main Methods:

• Comparative analysis of HIV-1 and HIV-2 infection dynamics and host responses.
• Investigation of spontaneous viral control in HIV-2 infected individuals.
• Examination of cross-immunity and viral control in HIV-1/HIV-2 dual infections.

Main Results:

• HIV-2 infection is associated with a larger proportion of individuals achieving long-term viral control compared to HIV-1.
• Elite controllers, individuals who spontaneously control HIV-1, are rare (0.15%), limiting statistical power in HIV-1 research.
• HIV-2's distinct characteristics present a valuable model for understanding viral control mechanisms.

Conclusions:

• HIV-2 serves as a potentially more powerful model than HIV-1 for elucidating mechanisms of spontaneous viral control.
• Understanding HIV-2's less pathogenic nature and long-term control can provide crucial insights for developing functional HIV cures.
• Investigating differences and cross-reactivity between HIV-1 and HIV-2 could unlock novel strategies for HIV vaccines and functional cures.